Logo image of CRMT

AMERICA'S CAR-MART INC (CRMT) Stock Fundamental Analysis

NASDAQ:CRMT - Nasdaq - US03062T1051 - Common Stock - Currency: USD

59.44  -1.74 (-2.84%)

After market: 59.44 0 (0%)

Fundamental Rating

3

Taking everything into account, CRMT scores 3 out of 10 in our fundamental rating. CRMT was compared to 122 industry peers in the Specialty Retail industry. CRMT has a bad profitability rating. Also its financial health evaluation is rather negative. CRMT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRMT had positive earnings in the past year.
CRMT had a negative operating cash flow in the past year.
CRMT had positive earnings in 4 of the past 5 years.
CRMT had a negative operating cash flow in each of the past 5 years.
CRMT Yearly Net Income VS EBIT VS OCF VS FCFCRMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

With a Return On Assets value of 0.48%, CRMT perfoms like the industry average, outperforming 51.64% of the companies in the same industry.
CRMT's Return On Equity of 1.38% is in line compared to the rest of the industry. CRMT outperforms 58.20% of its industry peers.
The Return On Invested Capital of CRMT (4.36%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.48%
ROE 1.38%
ROIC 4.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRMT Yearly ROA, ROE, ROICCRMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

CRMT has a Profit Margin of 0.55%. This is comparable to the rest of the industry: CRMT outperforms 53.28% of its industry peers.
CRMT's Profit Margin has declined in the last couple of years.
CRMT's Operating Margin of 5.93% is fine compared to the rest of the industry. CRMT outperforms 73.77% of its industry peers.
CRMT's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 47.52%, CRMT is doing good in the industry, outperforming 74.59% of the companies in the same industry.
CRMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.93%
PM (TTM) 0.55%
GM 47.52%
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
CRMT Yearly Profit, Operating, Gross MarginsCRMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for CRMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRMT Yearly Shares OutstandingCRMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CRMT Yearly Total Debt VS Total AssetsCRMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 1.94 indicates that CRMT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CRMT's Altman-Z score of 1.94 is in line compared to the rest of the industry. CRMT outperforms 43.44% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that CRMT has dependencies on debt financing.
The Debt to Equity ratio of CRMT (1.43) is worse than 63.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z 1.94
ROIC/WACC0.49
WACC8.87%
CRMT Yearly LT Debt VS Equity VS FCFCRMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.56 indicates that CRMT should not have too much problems paying its short term obligations.
CRMT's Current ratio of 1.56 is fine compared to the rest of the industry. CRMT outperforms 66.39% of its industry peers.
CRMT has a Quick Ratio of 1.56. This is a bad value and indicates that CRMT is not financially healthy enough and could expect problems in meeting its short term obligations.
CRMT has a Quick ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.42
CRMT Yearly Current Assets VS Current LiabilitesCRMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.05% over the past year.
Measured over the past years, CRMT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -30.02% on average per year.
CRMT shows a decrease in Revenue. In the last year, the revenue decreased by -0.21%.
CRMT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.31% yearly.
EPS 1Y (TTM)125.05%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%2000%
Revenue 1Y (TTM)-0.21%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%1.51%

3.2 Future

Based on estimates for the next years, CRMT will show a very strong growth in Earnings Per Share. The EPS will grow by 92.12% on average per year.
The Revenue is expected to grow by 8.59% on average over the next years. This is quite good.
EPS Next Y196.65%
EPS Next 2Y130.74%
EPS Next 3Y92.12%
EPS Next 5YN/A
Revenue Next Year10.36%
Revenue Next 2Y8.35%
Revenue Next 3Y8.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRMT Yearly Revenue VS EstimatesCRMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CRMT Yearly EPS VS EstimatesCRMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 47.94, CRMT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as CRMT.
When comparing the Price/Earnings ratio of CRMT to the average of the S&P500 Index (27.41), we can say CRMT is valued expensively.
With a Price/Forward Earnings ratio of 16.16, CRMT is valued correctly.
Based on the Price/Forward Earnings ratio, CRMT is valued a bit cheaper than the industry average as 63.11% of the companies are valued more expensively.
CRMT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 47.94
Fwd PE 16.16
CRMT Price Earnings VS Forward Price EarningsCRMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CRMT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.26
CRMT Per share dataCRMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

CRMT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRMT's earnings are expected to grow with 92.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y130.74%
EPS Next 3Y92.12%

0

5. Dividend

5.1 Amount

No dividends for CRMT!.
Industry RankSector Rank
Dividend Yield N/A

AMERICA'S CAR-MART INC

NASDAQ:CRMT (7/11/2025, 8:01:55 PM)

After market: 59.44 0 (0%)

59.44

-1.74 (-2.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-12 2025-06-12/bmo
Earnings (Next)09-02 2025-09-02/bmo
Inst Owners89.38%
Inst Owner Change0%
Ins Owners10.74%
Ins Owner Change-5.91%
Market Cap490.97M
Analysts51.11
Price Target53.55 (-9.91%)
Short Float %12.05%
Short Ratio9.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)1.32%
DP0.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)44.84%
Min EPS beat(2)-140.1%
Max EPS beat(2)229.77%
EPS beat(4)1
Avg EPS beat(4)-31.47%
Min EPS beat(4)-140.1%
Max EPS beat(4)229.77%
EPS beat(8)1
Avg EPS beat(8)-121.19%
EPS beat(12)2
Avg EPS beat(12)-92.73%
EPS beat(16)5
Avg EPS beat(16)-62.37%
Revenue beat(2)2
Avg Revenue beat(2)4.39%
Min Revenue beat(2)0.63%
Max Revenue beat(2)8.15%
Revenue beat(4)3
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)8.15%
Revenue beat(8)5
Avg Revenue beat(8)-0.02%
Revenue beat(12)8
Avg Revenue beat(12)1.72%
Revenue beat(16)12
Avg Revenue beat(16)3.84%
PT rev (1m)3.45%
PT rev (3m)0.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.41%
EPS NY rev (1m)-3.75%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.85%
Revenue NY rev (1m)5.97%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 47.94
Fwd PE 16.16
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 0.92
EV/EBITDA 14.26
EPS(TTM)1.24
EY2.09%
EPS(NY)3.68
Fwd EY6.19%
FCF(TTM)-10.06
FCFYN/A
OCF(TTM)-9.53
OCFYN/A
SpS167.73
BVpS67.58
TBVpS64.82
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 1.38%
ROCE 5.55%
ROIC 4.36%
ROICexc 4.39%
ROICexgc 4.46%
OM 5.93%
PM (TTM) 0.55%
GM 47.52%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.53%
OM growth 5Y-7.04%
PM growth 3Y-45.5%
PM growth 5Y-28.51%
GM growth 3Y2.42%
GM growth 5Y-0.01%
F-Score5
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA 8.89
Cap/Depr 58.51%
Cap/Sales 0.32%
Interest Coverage 1.06
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.42
Altman-Z 1.94
F-Score5
WACC8.87%
ROIC/WACC0.49
Cap/Depr(3y)178.2%
Cap/Depr(5y)233.45%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.05%
EPS 3Y-55.08%
EPS 5Y-30.02%
EPS Q2Q%2000%
EPS Next Y196.65%
EPS Next 2Y130.74%
EPS Next 3Y92.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.21%
Revenue growth 3Y5.17%
Revenue growth 5Y13.31%
Sales Q2Q%1.51%
Revenue Next Year10.36%
Revenue Next 2Y8.35%
Revenue Next 3Y8.59%
Revenue Next 5YN/A
EBIT growth 1Y267.14%
EBIT growth 3Y-11.16%
EBIT growth 5Y5.33%
EBIT Next Year613.24%
EBIT Next 3Y123%
EBIT Next 5YN/A
FCF growth 1Y-3.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.16%
OCF growth 3YN/A
OCF growth 5YN/A